Log In
Print
BCIQ
Print
Print this Print this
 

Adempas, riociguat (BAY 63-2521)

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionOral soluble guanylyl cyclase (sGC) stimulator
Molecular Target Soluble guanylyl cyclase (sGC)
Mechanism of ActionGuanylyl cyclase activator
Therapeutic ModalityBiologic: Enzyme

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$2,100.0M

$1,000.0M

$1,100.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today